SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-022340
Filing Date
2017-03-22
Accepted
2017-03-22 17:05:12
Documents
2
Period of Report
2017-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3779
2 POA DOCUMENT poa.txt EX-24.4_713704 3222
  Complete submission text file 0001209191-17-022340.txt   8485
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Patni Rajiv (Reporting) CIK: 0001616200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 17707337